Evidence map›Paper›PMID 39728226›Full record

ArticleJournal of imaging2024

The Use of Hybrid CNN-RNN Deep Learning Models to Discriminate Tumor Tissue in Dynamic Breast Thermography.

Andrés Munguía-Siu, Irene Vergara, Juan Horacio Espinoza-Rodríguez

Abstract read
In one paragraph

Article in Journal of imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrés Munguía-SiuDepartment of Computing, Electronics and Mechatronics, Universidad de las Américas Puebla, Sta. Catarina Martir, San Andrés Cholula 72810, Mexico.ORCID 0000-0002-2622-7188
Irene VergaraDepartment of Immunology, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Juan Horacio Espinoza-RodríguezDepartment of Computing, Electronics and Mechatronics, Universidad de las Américas Puebla, Sta. Catarina Martir, San Andrés Cholula 72810, Mexico.ORCID 0000-0002-2602-660X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is one of the leading causes of death for women worldwide, and early detection can help reduce the death rate. Infrared thermography has gained popularity as a non-invasive and rapid method for detecting this pathology and can be further enhanced by applying neural networks to extract spatial and even temporal data derived from breast thermographic images if they are acquired sequentially. In this study, we evaluated hybrid convolutional-recurrent neural network (CNN-RNN) models based on five state-of-the-art pre-trained CNN architectures coupled with three RNNs to discern tumor abnormalities in dynamic breast thermographic images. The hybrid architecture that achieved the best performance for detecting breast cancer was VGG16-LSTM, which showed accuracy (ACC), sensitivity (SENS), and specificity (SPEC) of 95.72%, 92.76%, and 98.68%, respectively, with a CPU runtime of 3.9 s. However, the hybrid architecture that showed the fastest CPU runtime was AlexNet-RNN with 0.61 s, although with lower performance (ACC: 80.59%, SENS: 68.52%, SPEC: 92.76%), but still superior to AlexNet (ACC: 69.41%, SENS: 52.63%, SPEC: 86.18%) with 0.44 s. Our findings show that hybrid CNN-RNN models outperform stand-alone CNN models, indicating that temporal data recovery from dynamic breast thermographs is possible without significantly compromising classifier runtime.

Indexed as

binary classificationbreast cancerCNN-RNNdeep learningneural networksthermography

Identifiers

PMID39728226
PMCPMC11728322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.